1. A tolerability burden index in schizophrenia: incorporating patient perspective in clinical trial adverse event reporting. Issue 1 (1st January 2017) Authors: François, Clément; Guiraud-Diawara, Alice; Lançon, Christophe; Llorca, Pierre Michel; Hartry, Ann; Hammer-Helmich, Lene; Zighed, Djamel A.; Tanasescu, Adrian; Toumi, Mondher Journal: Journal of market access & health policy Issue: Volume 5:Issue 1(2017) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. All-cause hospitalization and associated costs in patients with schizophrenia or bipolar disorder initiating long-acting injectable antipsychotics. (2nd January 2018) Authors: Yan, Tingjian; Greene, Mallik; Chang, Eunice; Hartry, Ann; Touya, Maëlys; Broder, Michael S. Journal: Current medical research and opinion Issue: Volume 34:Number 1(2018) Page Start: 41 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Assessing the burden of treatment-emergent adverse events associated with atypical antipsychotic medications. Issue 1 (December 2017) Authors: Llorca, Pierre-Michel; Lançon, Christophe; Hartry, Ann; Brown, T.; DiBenedetti, Dana; Kamat, Siddhesh; François, Clément Journal: BMC psychiatry Issue: Volume 17:Issue 1(2017) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Atypical antipsychotic adherence is associated with lower inpatient utilization and cost in bipolar I disorder. (2nd January 2019) Authors: Broder, Michael S.; Greene, Mallik; Chang, Eunice; Hartry, Ann; Yan, Tingjian; Yermilov, Irina Journal: Journal of medical economics Issue: Volume 22:Number 1(2019) Page Start: 63 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Changes in healthcare resource use and costs associated with early versus delayed initiation of atypical antipsychotic adjunctive treatment in major depressive disorder. (2nd September 2018) Authors: Seetasith, Arpamas; Greene, Mallik; Hartry, Ann; Burudpakdee, Chakkarin Journal: Journal of medical economics Issue: Volume 21:Number 9(2018) Page Start: 888 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Early initiation of long-acting injectable antipsychotic treatment is associated with lower hospitalization rates and healthcare costs in patients with schizophrenia: real-world evidence from US claims data. (3rd July 2019) Authors: Munday, Jennifer; Greene, Mallik; Chang, Eunice; Hartry, Ann; Yan, Tingjian; Broder, Michael S. Journal: Current medical research and opinion Issue: Volume 35:Number 7(2019) Page Start: 1231 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Evaluation of what matters most in existing clinical outcomes assessments in Alzheimer's disease: Neuropsychiatry and behavioral neurology/treatment development and clinical trials. (7th December 2020) Authors: Hartry, Ann; Menne, Heather; Wronski, Samantha L.; Paulsen, Russ; Callahan, Leigh F.; Potashman, Michele; Lee, Daniel; Wunderlich, Glen; Hoffman, Deborah; Wieberg, Dan; Kremer, Ian N.; Hauber, Brett; DiBenedetti, Dana B. Journal: Alzheimer's & dementia Issue: Volume 16(2020)Supplement 6 Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. F56. IMPACT OF SIDE EFFECTS DUE TO SECOND-GENERATION ANTIPSYCHOTICS ON THE FUNCTIONING OF PATIENTS WITH SCHIZOPHRENIA: AN OBSERVATIONAL, PATIENT CENTERED, WEB SURVEY. (1st April 2018) Authors: Tandon, Rajiv; Weiss, Catherine; Lenderking, William; Cooper, Owen; Shalhoub, Huda; Kleinman, Leah; Chen, Jun; Hartry, Ann; Green, Mallik; Meehan, Stine R; Douvold, Laëtitia Bouérat Journal: Schizophrenia bulletin Issue: Volume 44(2018)Supplement 1 Page Start: S241 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. F75. MEDICATION ADHERENCE AND DISCONTINUATION IN PATIENTS WITH SCHIZOPHRENIA TREATED WITH ARIPIPRAZOLE ONCE-MONTHLY LONG-ACTING INJECTABLE VERSUS THOSE TREATED WITH ORAL ANTIPSYCHOTICS. (1st April 2018) Authors: Greene, Mallik; Yan, Tingjian; Chang, Eunice; Hartry, Ann; Pulasky, Beth Journal: Schizophrenia bulletin Issue: Volume 44(2018)Supplement 1 Page Start: S248 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. F75. MEDICATION ADHERENCE AND DISCONTINUATION IN PATIENTS WITH SCHIZOPHRENIA TREATED WITH ARIPIPRAZOLE ONCE-MONTHLY LONG-ACTING INJECTABLE VERSUS THOSE TREATED WITH ORAL ANTIPSYCHOTICS. (1st April 2018) Authors: Greene, Mallik; Yan, Tingjian; Chang, Eunice; Hartry, Ann; Pulasky, Beth Journal: Schizophrenia bulletin Issue: Volume 44(2018)Supplement 1 Page Start: S248 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗